Skip to main content
Ying Kong on Muck Rack

Ying Kong

As seen in: Color Research & Application, Nature, Wiley Online Library, PLOS ONE, Frontiers in Immunology, MDPI, ACS Publications, Diagnostic Pathology, Royal Society of Chemistry, Cell Press and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ying

Contact Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression

|
By Xing Wang, Yuhan Tan, Ju Wang, Ying Kong
| Frontiers in Immunology
Abstract Background: Although cullin-family E3 ubiquitin ligases regulate diverse oncogenic pathways, the role of CACUL1 in hepatocellular carcinoma (HCC) remains poorly characterized. Methods: We performed pan-cancer expression and survival analysis using TCGA and GEO databases, validated findings through immunohistochemistry, and conducted functional studies in HCC cell lines using CRISPR-mediated CACUL1 knockout.
Open in Who Shared Issue with article?

Understanding hypoparathyroidism as a disease of broad functional deficiency

|
By Maria Luisa Brandi, Jean-Philippe Bertocchio, István Károly Takács, Ying Kong, Lars Rejnmark, Aliya Khan, Ellen K. Colman
| Cell Press Verified
ReviewOnline nowOpen access Affiliations & Notes 1FIRMO Italian Foundation for the Research on Bone Diseases, Florence, Italy 2Thyroid-Endocrine Tumors Department, Pitié-Salpêtrière Hospital, AP-HP, Paris, France 3Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary 4Global Medical Affairs, Alexion, AstraZeneca Rare Disease, Boston, MA, USA 5Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark 6Division of...
Open in Who Shared Issue with article?

Predictive Screening of Ta 4 C 3 MXene as an Inhalable Nanotherapeutic Based on an Advanced 3D Air–Liquid Interface Lung Model Click to copy article link Article link copied!

|
By Ying Kong, Fuze Jiang, Nicole J. Machi
| dx.doi.org
Pulmonary diseases, such as acute lung injury and fibrosis, represent a significant global health burden, necessitating innovative therapeutic strategies that can directly target the affected tissue with minimal systemic exposure. Inhalation-based drug administration offers a noninvasive approach for treating pulmonary diseases by delivering therapeutics directly to the lungs while reducing systemic side effects.
Open in Who Shared Issue with article?
See all 50 articles